Theleme Partners LLP
In its 13F for Q2 2025 (holdings as of June 30, 2025, filed August 14, 2025), Theleme Partners LLP reported 10 stock positions worth $1.6 billion. Its top holding was Moderna (MRNA) at 13.2% of the portfolio, followed by Wells Fargo (WFC, 12.9%) and Meta Platforms Class A (META, 12.2%). Compared with Q1 2025, it opened 1 new position, sold out of 3, added to 6 and reduced 2. The biggest buy was a new position in Meta Platforms Class A (META) and the biggest sale an exit from Skechers USA Class A (SKX).
- Most Recent 13F
- Q2 2026
- Location
- London, X0
- CIK
- 0001511881
- Portfolio Value
- $1.6B (Q2 2025)
- SEC Filing
- 0000919574-25-004639 ↗ filed Aug 14, 2025
Holdings Value
Holdings 10 stocks · $1.6B
| MRNA Moderna Inc. | 13.20% | 7,868,810 | $217.1M | Add +8.7% |
| WFC Wells Fargo & Co. | 12.87% | 2,643,000 | $211.8M | Add +24.5% |
| META Meta Platforms Inc. Class A | 12.16% | 271,000 | $200.0M | New |
| TRU Transunion | 11.28% | 2,108,357 | $185.5M | Add +16.1% |
| FLUT Flutter Entertainment PLC-Di | 11.18% | 643,528 | $183.9M | Add +73.2% |
| BAC Bank of America Corp. filed as BANK AMERICA CORP | 10.32% | 3,586,800 | $169.7M | Add +3.2% |
| UBER Uber Technologies Inc. | 9.58% | 1,689,750 | $157.7M | Add +10.5% |
| EFX Equifax Inc. | 9.43% | 598,088 | $155.1M | No change |
| AMZN Amazon.com Inc. | 9.17% | 688,000 | $150.9M | Reduce -19.1% |
| HDB HDFC Bank Ltd.-ADR | 0.82% | 175,800 | $13.5M | Reduce -64.9% |
Portfolio Sells Q1 2025 → Q2 2025
Portfolio Buys Q1 2025 → Q2 2025
| META Meta Platforms Inc. Class A | New | 12.16% | +12.16 |
| FLUT Flutter Entertainment PLC-Di | Add +73.2% | 11.18% | +4.71 |
| WFC Wells Fargo & Co. | Add +24.5% | 12.87% | +0.89 |
| UBER Uber Technologies Inc. | Add +10.5% | 9.58% | +0.82 |
| TRU Transunion | Add +16.1% | 11.28% | −0.56 |
| BAC Bank of America Corp. | Add +3.2% | 10.32% | −1.08 |
| MRNA Moderna Inc. | Add +8.7% | 13.20% | −2.94 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 9 | $1.7B | MRNA, META, UBER, AMZN, TRU |
| Q1 2026 | 9 | $1.5B | MRNA, META, UBER, TRU, AMZN |
| Q4 2025 | 9 | $1.5B | META, MRNA, FLUT, TRU, WFC |
| Q3 2025 | 10 | $1.6B | META, WFC, MRNA, TRU, UBER |
| Q2 2025 | 10 | $1.6B | MRNA, WFC, META, TRU, FLUT |
| Q1 2025 | 12 | $1.3B | MRNA, AMZN, WFC, TRU, EFX |
| Q4 2024 | 11 | $1.5B | MRNA, BAC, WFC, AMZN, EFX |
| Q3 2024 | 10 | $1.7B | MRNA, SCHW, TRU, EFX, HRI |
| Q2 2024 | 8 | $2.0B | MRNA, SCHW, WFC, TRU, HRI |
| Q1 2024 | 7 | $1.8B | MRNA, SCHW, WFC, HRI, TRU |